Nu-Med Plus (NUMD) Shares Outstanding (2011 - 2026)

Nu-Med Plus has disclosed Shares Outstanding (Entity) across 16 years of filings, most recently posting $83.5 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) changed 0.0% year-over-year to $83.5 million; the TTM figure through Jun 2026 stood at $83.5 million (changed 0.0% YoY), while the FY2025 annual figure was $83.5 million, changed 0.0% from the prior year.
• Shares Outstanding (Entity) came in at $83.5 million for Q2 2026 at Nu-Med Plus, roughly flat from $83.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $83.5 million in Q4 2023 to a low of $79.3 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $82.4 million, with a median of $83.5 million recorded in 2023.
• Year-over-year, Shares Outstanding (Entity) changed 0.0% in 2022 and advanced 2.7% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $81.3 million in 2022, then rose by 2.7% to $83.5 million in 2023, then changed by 0.0% to $83.5 million in 2024, then changed by 0.0% to $83.5 million in 2025, then changed by 0.0% to $83.5 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $83.5 million in Q2 2026, $83.5 million in Q4 2025, and $83.5 million in Q3 2025.